Dr. Srdan Verstovsek presents results from Ropeginterferon vs Hydroxyurea study at MPN Asia 2018

MPN News | May 9, 2018

After a 2 year study, Ropeginterferon proves more effective than Hydroxyurea in symptom improvement and lowering progression rates

Read More

Free webinar for MPN patients and caregivers

MPN News | April 23, 2018

NCCN to host 2 events focused on education

Read More

myMPN data shows trends for PV, ET and MF

MPN News | April 16, 2018

Users with PV, ET and MF are entering symptom data across the country

Read More

MPN Alliance Australia and MPN Research Foundation Partner to support research

MPN News

MPNAA and MPNRF work together to better understand interferon

Read More

Blood article by MD Anderson researchers looks back at 107 MF patients who discontinued Jakafi

MPN News | March 22, 2018

Authors describe epigenetic mutations in some patients and suggest follow up research is needed

Read More

CR&T Shares videos from their 8th International MPN conference

MPN News | March 6, 2018

Watch video updates from MPN experts

Read More

CTI Biopharma expands it's clinical Trial

MPN News | March 1, 2018

CTI Biopharma is recruiting patients for the PAC203 study, a randomized phase 2 trial evaluating different doses of pacritinb in myelofibrosis patients. Previously, patients had to have a platelet count less than 100,000.

Read More

Recognizing some of the women in the MPN community

MPN News | March 6, 2018

March 8th is International Women's Day

Read More
MPN News | February 28, 2018

“Beyond Blue,” a short documentary by an award‐winning filmmaker, debuts to raise awareness of MPNs

Read More

Constellation Pharmaceuticals announced a Phase 2 study of CPI-0610 in patients with myelofibrosis.

MPN News | March 7, 2018

Constellation Pharmaceuticals announced a Phase 2 study of CPI-0610 alone or in combination with ruxolitinib in patients with myelofibrosis.

Read More

Asana BioSciences Announces a Phase II trial in patients with MF

MPN News | February 14, 2018

Asana BioSciences announces a Phase II study in patients with myelofibrosis is in progress in the US.

Read More

Read about the life of the Founder of MPNRF

MPN News | January 12, 2018

Obituary for Robert Rosen, Founder of the MPN Research Foundation

Read More

Celgene buys maker of Fedratinib

MPN News | January 9, 2018

Fedratinib may be approved for patients resistant to or intolerant of Jakafi

Read More

Two MPN experts discuss ASH 2017

MPN News | December 21, 2017

Return of old drugs, update to prognostic scoring system and more

Read More

Video updates from ASH 2017

MPN News | December 19, 2017

Four experts weigh in on the MPN updates

Read More

Check our News - Archive for older news.

Get updates on MPN patients and research breakthroughs.

What are the latest developments in MPN Research?